We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

EKF Diagnostics

EKF Diagnostics is a leading global diagnostics and biotechnology company that delivers advanced solutions in point-o... read more Featured Products: More products

Download Mobile App





EKF Diagnostics Showcases Advanced Point-of-Care and Connectivity Technologies

By LabMedica International staff writers
Posted on 17 Nov 2025

Clinical laboratories and near‑patient providers need rapid, reliable measurement of hemoglobin, HbA1c, glucose, and lactate, alongside secure device connectivity to support timely decisions. More...

EKF Diagnostics is showcasing point‑of‑care (POC) and integration technologies addressing these needs at MEDICA 2025 in Düsseldorf, Germany.

At Hall 3, Booth B69, EKF is presenting a portfolio spanning handheld and desktop analyzers and connectivity software for clinical and near‑patient use. The lineup includes the DiaSpect Tm handheld hemoglobin analyzer, which is ideal for use in any blood screening setting, even in challenging climatic and remote environments. DiaSpect Tm’s proven technology provides laboratory-quality results in just one second and transfers the test result data via Bluetooth or wired connection to EKF Link in real time.

Also being showcased is Hemo Control, a POC hemoglobin analyzer with hematocrit estimation designed to deliver fast, reliable results across a wide range of healthcare settings. Hemo Control uses the most established photometric azide methemoglobin method, ensuring reliable results with a high precision (CV <2%). It is used in blood banks, hospitals, and doctors’ offices for routine POC anemia screening.

For diabetes care, EKF is featuring the Biosen C‑Line for glucose and lactate measurement in laboratories, sports medicine, and diabetes clinics. Biosen uses special chip-sensor technology to deliver rapid, high-accuracy results at a low cost per test. The long lifespan of the sensor chip keeps maintenance to a minimum, while features such as the color touchscreen and large memory further enhance the analyzer’s user-friendliness. The Biosen series of glucose analyzers includes two models: the Biosen C-Line Clinic and the Biosen C-Line GP+.

Also on display is the Quo-Test fully automated desktop analyzer that provides easy and reliable HbA1c measurement for the monitoring and management of diabetes in a point-of-care setting. The Quo-Test HbA1c system uses patented boronate affinity fluorescence quenching technology to measure glycated hemoglobin from just 4 μl of capillary or venous whole blood. Sample results are available within four minutes and are dual-reported in IFCC and DCCT standard units, with Mono S and JDS reporting also available.

Complementing the analyzers is EKF Link, a powerful middleware solution that centralizes data management for POC analyzers on a single platform. This flexible, open data-management solution integrates seamlessly with most vendors’ POC devices, allowing real-time management of patient test results, quality control (QC) data, operator management, and analyzer configuration. Its adaptability and ease of use make EKF Link a valuable connectivity solution for hospitals, laboratories, blood banks, pharmacies, and general practitioners (GPs).

Related Links:

EKF Diagnostics
 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Silver Member
Vitamin D Assay
EZ Vitamin D Assay
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.